José Baselga, the former chief medical officer of Memorial Sloan Kettering Cancer Center, has now resigned as editor-in-chief of the journal Cancer Discovery, according to the New York Times and ProPublica.
In September, the Times and ProPublica reported that Baselga had omitted payments he had received from drug or healthcare companies when he made conflict-of-interest disclosures to research journals about 60 percent of the time. This led to Baselga resigning as MSKCC's chief medical officer.
And has now led, the Times and ProPublica report, to Baselga's resignation from his position at Cancer Discovery. "Dr. Baselga did not adhere to the high standards pertaining to conflict of interest disclosures that the AACR expects of its leadership," the American Association for Cancer Research, which publishes the journal, said in an email to its members, according to the Times and ProPublica. "Consequently, Dr. Baselga was asked to resign from his role at the journal."
The Times and ProPublica add that AACR says Baselga will still be allowed to publish in its journals as his failure to make those disclosures was unintentional. Baselga previously served as AACR president.